Reuters logo
BRIEF-AC Immune completes recruitment for low-dose cohort in world's first clinical trial for Anti-Abeta Vaccine
September 12, 2017 / 10:28 AM / 2 months ago

BRIEF-AC Immune completes recruitment for low-dose cohort in world's first clinical trial for Anti-Abeta Vaccine

Sept 12 (Reuters) - Ac Immune Ltd

* AC Immune completes recruitment for low-dose Cohort in world’s first clinical trial for Anti-Abeta Vaccine targeting alzheimer’s disease-like characteristics in individuals with down syndrome Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below